According to Kamada 's latest financial reports the company's current revenue (TTM) is $0.14 B. In 2022 the company made a revenue of $0.12 B an increase over the years 2021 revenue that were of $0.10 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.14 B | 10.19% |
2022 | $0.12 B | 24.79% |
2021 | $0.10 B | -22.22% |
2020 | $0.13 B | 4.76% |
2019 | $0.12 B | 11.11% |
2018 | $0.11 B | 11.32% |
2017 | $0.10 B | 32.69% |
2016 | $77.49 M | 10.85% |
2015 | $69.9 M | -1.63% |
2014 | $71.06 M | 0.63% |
2013 | $70.62 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Vertex Pharmaceuticals VRTX | $9.86 B | 6,824.83% | ๐บ๐ธ USA |
Compugen CGEN | $33.45 M | -76.52% | ๐ฎ๐ฑ Israel |